Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABEONA THERAPEUTICS INC. Director's Dealing 2019

May 23, 2019

33413_dirs_2019-05-23_4d60b5c0-6487-4900-9730-0460f3f49186.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2019-05-21

Reporting Person: Buono Stefano (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-21 Stock Option (right to buy) $7.42 A 19827 Acquired 2029-05-21 Common stock (19827) Direct